Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a reversed-phase high-performance liquid chromatography method for quantification of allantoin, creatinine, and uric acid in individual spot cow urine samples.

JDS communications·2026
Same author

Expansion of the geographic distribution and morphological aspects of Braga patagonica (Isopoda: Cymothoidae) to Eastern Amazon, Brazil.

Brazilian journal of biology = Revista brasleira de biologia·2025
Same author

Effects of nano- and micro- fibers derived from surgical face masks in Danio rerio.

Aquatic toxicology (Amsterdam, Netherlands)·2025
Same author

Predictive accuracy of time series models applied to economic data: the European countries retail trade.

Journal of applied statistics·2024
Same author

Efficacy of levamisole, ivermectin and moxidectin against Capillaria spp. in European hedgehogs (Erinaceus europaeus) - CORRIGENDUM.

Journal of helminthology·2024
Same author

Using a food web model to predict the effects of Hazardous and Noxious Substances (HNS) accidental spills on deep-sea hydrothermal vents from the Mid-Atlantic Ridge (MAR) region.

Marine pollution bulletin·2024

Related Experiment Video

Updated: Mar 3, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K

Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges.

J Barroca-Ferreira1, J P Pais1, M M Santos1

  • 1CICS-UBI- Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilha, Portugal.

Current Cancer Drug Targets
|May 3, 2017
PubMed
Summary
This summary is machine-generated.

Six-transmembrane epithelial antigen of the prostate (STEAP1) is overexpressed in cancers, suggesting its potential as a therapeutic target. This review explores STEAP1

Keywords:
CancerDNA vaccinesMonoclonal antibodiesSTEAP1Small noncoding RNAprostate cancer.

More Related Videos

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.7K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K

Related Experiment Videos

Last Updated: Mar 3, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.2K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.7K
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Six-transmembrane epithelial antigen of the prostate (STEAP1) is overexpressed in various human cancers, including prostate cancer (PCa).
  • STEAP1's cell membrane location and structure suggest a role in tumor cell communication.
  • Its high specificity and overexpression make STEAP1 a promising therapeutic target.

Purpose of the Study:

  • To review current knowledge on STEAP1 protein expression and biochemical properties.
  • To evaluate various strategies for targeting STEAP1 in cancer therapy.
  • To assess STEAP1's potential as a therapeutic agent for cancer treatment.

Main Methods:

  • Literature review of studies on STEAP1 expression, function, and targeting strategies.
  • Analysis of biochemical properties and cellular localization of STEAP1.
  • Compilation of data on developed therapeutic approaches against STEAP1.

Main Results:

  • STEAP1 is confirmed to be overexpressed in multiple cancer types.
  • Its role in intercellular communication is a key aspect of its oncogenic function.
  • Diverse targeting strategies, including antibody-drug conjugates and vaccines, have been developed.

Conclusions:

  • STEAP1 is a highly specific and overexpressed cancer biomarker.
  • Targeting STEAP1 presents a promising therapeutic avenue for various cancers.
  • Further research into STEAP1-targeting agents could lead to novel cancer treatments.